Tower Research Capital LLC (Trc) Arcutis Biotherapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,743 shares of ARQT stock, worth $110,861. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,743

Previous 18,920 53.79%

Holding current value

$110,861

Previous $175,000 53.71%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.32 - $11.0 $84,672 - $111,947	-10,177 Reduced 53.79%	8,743 $81,000
Q2 2024 Aug 13, 2024	BUY	$7.24 - $12.53 $119,691 - $207,145	16,532 Added 692.29%	18,920 $175,000
Q1 2024 May 15, 2024	SELL	$3.25 - $11.77 $6,600 - $23,904	-2,031 Reduced 45.96%	2,388 $23,000
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $1,023 - $2,679	556 Added 14.39%	4,419 $14,000
Q3 2023 Nov 14, 2023	SELL	$5.31 - $10.98 $43,159 - $89,245	-8,128 Reduced 67.78%	3,863 $20,000
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $70,346 - $140,505	9,367 Added 356.97%	11,991 $114,000
Q1 2023 May 09, 2023	SELL	$10.23 - $17.14 $63,845 - $106,970	-6,241 Reduced 70.4%	2,624 $29,000
Q4 2022 Feb 10, 2023	BUY	$13.96 - $20.4 $84,248 - $123,113	6,035 Added 213.25%	8,865 $131,000
Q3 2022 Nov 10, 2022	SELL	$17.85 - $26.95 $161,488 - $243,816	-9,047 Reduced 76.17%	2,830 $54,000
Q2 2022 Aug 15, 2022	BUY	$16.33 - $22.2 $179,923 - $244,599	11,018 Added 1282.65%	11,877 $253,000
Q1 2022 May 12, 2022	SELL	$14.38 - $22.79 $13,517 - $21,422	-940 Reduced 52.25%	859 $16,000
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $12,028 - $20,476	803 Added 80.62%	1,799 $38,000
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $35,860 - $50,406	-1,860 Reduced 65.13%	996 $23,000
Q2 2021 Aug 16, 2021	BUY	$24.42 - $34.75 $39,731 - $56,538	1,627 Added 132.38%	2,856 $78,000
Q1 2021 May 17, 2021	BUY	$24.47 - $36.98 $20,775 - $31,396	849 Added 223.42%	1,229 $36,000
Q4 2020 Feb 16, 2021	SELL	$17.82 - $31.73 $195,307 - $347,760	-10,960 Reduced 96.65%	380 $11,000
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $228,680 - $314,923	9,756 Added 615.91%	11,340 $332,000
Q2 2020 Aug 13, 2020	BUY	$24.48 - $36.56 $7,882 - $11,772	322 Added 25.52%	1,584 $48,000
Q1 2020 May 15, 2020	BUY	$18.5 - $36.9 $23,347 - $46,567	1,262 New	1,262 $38,000

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $763M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Arcutis Biotherapeutics, Inc. Transaction History